Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04685772 · ClinicalTrials.gov registry record
Assessment of the Efficacy of Medrol Dose Pack for Acute Post-Concussive Headaches
A clinical trial of Headache and Post-Concussion Syndrome, sponsored by Northwell Health.
- Recruiting
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT04685772: Recruiting study of Headache and Post-Concussion Syndrome, sponsored by Northwell Health.
NCT04685772 is a study of Headache and Post-Concussion Syndrome that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 25 participants, below the 155-participant average among 35 other Headache trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04685772, a study of Headache and Post-Concussion Syndrome, is actively recruiting participants, sponsored by Northwell Health.
- RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This novel pilot project will assess the effectiveness of corticosteroids in treatment of acute post-concussion headache. The investigators hypothesize that the use of corticosteroids will cause significant headache reduction in frequency and/or intensity than individuals who undergo the current standard of care. Additionally, the investigators hypothesize that corticosteroid use will lead to a reduction in other somatic symptoms including vestibular symptoms, leading to quicker return to school, work, and/or ability to play sports.
Primary Outcome
Defined as change in headache in response to medication
Conditions Studied
Interventions
- DRUG Methylprednisolone
Study Locations (1)
New York
- Northwell Health - North Shore University Hospital - Manhasset
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2021-04-01 |
| Est. Completion | 2026-12-01 |
What NCT04685772 shows while recruiting
NCT04685772 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 155-participant average among 35 other Headache trials with a reported enrollment target (84% lower).
The record links to 2 conditions, with Headache appearing as the primary indexed condition, and to 1 intervention - of which Methylprednisolone is the first listed.
NCT04685772 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04685772 about?
NCT04685772 is a clinical study titled "Assessment of the Efficacy of Medrol Dose Pack for Acute Post-Concussive Headaches". This novel pilot project will assess the effectiveness of corticosteroids in treatment of acute post-concussion headache. The investigators hypothesize that the use of corticosteroids will cause significant headache reduction in frequency and/or intensity than individuals who undergo the current sta...
What is the current status of trial NCT04685772?
This trial is currently recruiting. The enrollment target is 25 participants. The study started on 2021-04-01. Estimated completion is 2026-12-01.
What conditions does trial NCT04685772 study?
This clinical trial studies the following conditions: Headache, Post-Concussion Syndrome.
What interventions are being tested in trial NCT04685772?
The interventions under investigation include: Methylprednisolone (DRUG).
Who is sponsoring clinical trial NCT04685772?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04685772 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Headache
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04685772's enrollment target sits among peer trials
25 31st of 35 higher than 5 of 35 other Headache trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Headache trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Concussion Recovery and Support Program
RECRUITING · NA
-
Personalized Brain Stimulation to Treat Chronic Concussive Symptoms
RECRUITING · Phase 2
-
Lidocaine Infusion Treatment for Subarachnoid Hemorrhage Headaches
RECRUITING
-
Puberty, Testosterone, and Brain Development
RECRUITING
-
Responding With Evidence and Access for Childhood Headaches
RECRUITING · NA
-
Determining the Utility of a Behavioral Intervention in Chronic Migraine
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI